Jennison Associates
TYRA icon

Jennison Associates’s Tyra Biosciences TYRA Stock Holding History

Jennison Associates’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Sell
450,964
-181,468
-29% -$6M 0.01% 367
2026
Q1 		$24.2M Buy
+632,432
New +$20.5M 0.02% 307
2024
Q4 		– Sell
-158,187
Closed -$3.72M – 631
2024
Q3 		$3.72M Buy
158,187
+8,837
+6% +$186K ﹤0.01% 420
2024
Q2 		$2.39M Buy
+149,350
New +$2.57M ﹤0.01% 440
2021
Q4 		– Sell
-468,750
Closed -$8.24M – 729
2021
Q3 		$8.24M Buy
+468,750
New +$8.96M 0.01% 462

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jennison Associates's TYRA Position: Q2 2026 in Review

Jennison Associates reduced its Tyra Biosciences (TYRA) stake by 29% in Q2 2026, selling an estimated $6M and leaving 450,964 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #367.

Jennison Associates first reported a position in TYRA in Q3 2021 and has held it in 5 quarters since. The position peaked at $24.2M in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Jennison Associates held 450,964 shares of Tyra Biosciences worth $14.4M as of Q2 2026.
  • Jennison Associates sold 181,468 Tyra Biosciences shares in Q2 2026, an estimated $6M.
  • Tyra Biosciences made up 0.01% of Jennison Associates's portfolio in Q2 2026, its #367 holding.
  • Jennison Associates first reported a position in Tyra Biosciences in Q3 2021 and has held it in 5 quarters since.
  • Jennison Associates's Tyra Biosciences position peaked at $24.2M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.